Page last updated: 2024-09-02

fingolimod hydrochloride and Aggression

fingolimod hydrochloride has been researched along with Aggression in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cascione, M; Cree, BAC; Meng, X; Schofield, L; Tenenbaum, N; Wendt, J	1

Trials

1 trial(s) available for fingolimod hydrochloride and Aggression

Article	Year
Treatment retention on fingolimod compared with injectable multiple sclerosis therapies in African-American patients: A subgroup analysis of a randomized phase 4 study. Multiple sclerosis and related disorders, 2018, Volume: 25 Topics: Adolescent; Adult; Aged; Aggression; Black or African American; Disability Evaluation; Disease Progression; Female; Fingolimod Hydrochloride; Glatiramer Acetate; Humans; Immunosuppressive Agents; Interferon-beta; Male; Middle Aged; Multiple Sclerosis; Patient Satisfaction; Young Adult	2018

Article

Year

Treatment retention on fingolimod compared with injectable multiple sclerosis therapies in African-American patients: A subgroup analysis of a randomized phase 4 study.

Multiple sclerosis and related disorders, 2018, Volume: 25

Topics: Adolescent; Adult; Aged; Aggression; Black or African American; Disability Evaluation; Disease Progression; Female; Fingolimod Hydrochloride; Glatiramer Acetate; Humans; Immunosuppressive Agents; Interferon-beta; Male; Middle Aged; Multiple Sclerosis; Patient Satisfaction; Young Adult

2018